Drug intelligence / Profile preview

Clarastill Sine

Development stage
Unknown
Lead developer
Visum Pharm
Modality
Small Molecules
Administration
Ophthalmic
01

Overview

Clarastill Sine is a preservative-free ophthalmic solution developed by Visum Pharm, containing a combination of N-acetylcarnosine, carboxymethylcellulose, and glycerin. It is primarily indicated for the treatment of degenerative changes in the eye, such as cataracts, and for the relief of dry eye symptoms. N-acetylcarnosine acts as a prodrug for L-carnosine, which functions as a potent antioxidant and antiglycation agent within the aqueous humor and lens, helping to prevent and reduce the opacification of the lens. Carboxymethylcellulose and glycerin provide lubricating and osmoprotective effects on the ocular surface, alleviating irritation and maintaining tear film stability. The "Sine" designation indicates a formulation free of preservatives, making it suitable for patients with sensitive eyes or those requiring frequent application.

Brand names
Clarastill SineClarastill
Other names
N-acetylcarnosine eye drops
02

Targets

CRY (Crystallin family)

Beyond the preview

Go deeper on Clarastill Sine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Clarastill Sine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call